A detailed history of Gsa Capital Partners LLP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 54,350 shares of AMRX stock, worth $489,150. This represents 0.03% of its overall portfolio holdings.

Number of Shares
54,350
Previous 154,760 64.88%
Holding current value
$489,150
Previous $983,000 54.02%
% of portfolio
0.03%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$6.42 - $8.83 $644,632 - $886,620
-100,410 Reduced 64.88%
54,350 $452,000
Q2 2024

Aug 15, 2024

SELL
$5.36 - $7.11 $151,162 - $200,516
-28,202 Reduced 15.41%
154,760 $983,000
Q1 2024

May 03, 2024

BUY
$5.24 - $6.34 $958,720 - $1.16 Million
182,962 New
182,962 $1.11 Million
Q3 2023

Nov 15, 2023

SELL
$2.76 - $4.59 $251,891 - $418,906
-91,265 Reduced 79.88%
22,986 $97,000
Q2 2023

Aug 14, 2023

BUY
$1.33 - $3.1 $44,863 - $104,569
33,732 Added 41.89%
114,251 $354,000
Q1 2023

May 12, 2023

SELL
$1.27 - $2.7 $120,053 - $255,231
-94,530 Reduced 54.0%
80,519 $111,000
Q4 2022

Feb 13, 2023

BUY
$1.96 - $2.61 $343,096 - $456,877
175,049 New
175,049 $348,000
Q2 2022

Aug 09, 2022

BUY
$3.01 - $4.46 $132,111 - $195,753
43,891 Added 40.65%
151,865 $483,000
Q1 2022

May 11, 2022

BUY
$3.9 - $4.89 $290,830 - $364,657
74,572 Added 223.26%
107,974 $450,000
Q4 2021

Feb 14, 2022

BUY
$3.95 - $5.85 $131,937 - $195,401
33,402 New
33,402 $160,000
Q3 2021

Nov 12, 2021

SELL
$4.31 - $5.64 $479,271 - $627,168
-111,200 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$5.12 - $6.82 $442,024 - $588,791
86,333 Added 347.18%
111,200 $569,000
Q1 2021

May 10, 2021

SELL
$4.74 - $7.38 $69,606 - $108,375
-14,685 Reduced 37.13%
24,867 $167,000
Q4 2020

Feb 03, 2021

SELL
$3.95 - $5.42 $56,532 - $77,571
-14,312 Reduced 26.57%
39,552 $181,000
Q3 2020

Nov 06, 2020

BUY
$3.54 - $5.27 $14,029 - $20,885
3,963 Added 7.94%
53,864 $209,000
Q2 2020

Aug 11, 2020

SELL
$2.87 - $5.46 $138,730 - $263,925
-48,338 Reduced 49.2%
49,901 $238,000
Q1 2020

May 12, 2020

BUY
$2.46 - $5.35 $241,667 - $525,578
98,239 New
98,239 $342,000
Q3 2019

Nov 12, 2019

SELL
$2.29 - $7.1 $117,394 - $363,974
-51,264 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$6.44 - $14.29 $330,140 - $732,562
51,264 New
51,264 $368,000
Q1 2019

May 15, 2019

SELL
$11.87 - $14.84 $205,861 - $257,370
-17,343 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$13.09 - $21.49 $227,019 - $372,701
17,343 New
17,343 $235,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.36B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.